05-23-0101 Sigma-AldrichAngiotensin II, Human - CAS 4474-91-3 - Calbiochem
Plays an important role in the regulation of blood pressure.
More>> Plays an important role in the regulation of blood pressure. Less<<Sinónimos: DRVYIHPF
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
4474-91-3 | C₅₀H₇₁N₁₃O₁₂ |
Precios y disponibilidad
Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
---|---|---|---|---|---|---|
05-23-0101-1MG |
|
Ampolla de plást. | 1 mg |
|
— | |
05-23-0101-25MG |
|
Frasco de vidrio | 25 mg |
|
— | |
05-23-0101-5MG |
|
Ampolla de plást. | 5 mg |
|
— |
Product Information | |
---|---|
CAS number | 4474-91-3 |
ATP Competitive | N |
Form | White to off-white solid |
Hill Formula | C₅₀H₇₁N₁₃O₁₂ |
Chemical formula | C₅₀H₇₁N₁₃O₁₂ |
Hygroscopic | Hygroscopic |
Reversible | N |
Sold on the basis of peptide content | Y |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | adenylate cyclase activity |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Peptide Content | Y |
Peptide Sequence | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | BW2165000 |
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
05-23-0101-1MG | 04055977206906 |
05-23-0101-25MG | 04055977206913 |
05-23-0101-5MG | 04055977206920 |
Documentation
Licencias necesarias
Título |
---|
PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
Angiotensin II, Human - CAS 4474-91-3 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Angiotensin II, Human - CAS 4474-91-3 - Calbiochem Certificados de análisis
Cargo | Número de lote |
---|---|
05-23-0101 |
Referencias bibliográficas
Visión general referencias |
---|
Zhu, M., et al. 2000. J. Neurophysiol. 84, 2494. Natarajan, R., et al. 1999. Hypertension 33, 378. Mazzolai, L., et al. 1998. Hypertension 31, 1324. Earp, H.S., et al. 1995. J. Biol. Chem. 270, 28440. Ishida, M., et al. 1995. Circ. Res. 77, 1053. Vyas, S.J., and Jackson, E.K. 1995. J. Pharmacol. Exp. Ther. 273, 768. |